mash wegovy - Search News

Order byBest matchMost fresh

News

Wegovy becomes 1st GLP-1RA to gain FDA MASH approval

Fierce Pharma · 1d

Novo's Wegovy picks up 3rd indication with key FDA approval in the liver disease MASH

With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug approved in a severe form of fatty liver disease. | The FDA has signed off on an accelerated approval for Novo Nordisk's Wegovy to treat certain adults with metabolic-associated steatohepatitis.

Continue reading

BioPharma Dive · 1d

Novo’s Wegovy becomes first GLP-1 drug approved for MASH

Pharmaceutical Technology on MSN · 1d

Wegovy becomes first GLP-1RA to gain FDA MASH approval

Everyday Health1h

People With Weight-Related Chronic Liver Disease Have a New Treatment Option

The U.S. Food and Drug Administration approved the obesity drug Wegovy for people with the chronic liver disease known as ...

Wegovy Approved for MASH With Fibrosis, No Cirrhosis

Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...

1d

A Common Weight Loss Drug Can Treat Severe Liver Disease, F.D.A. Says

The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...

Health and Me on MSN1d

Wegovy Approved For MASH Treatment With Fibrosis But No Cirrhosis

FDA has approved Novo Nordisk's Wegovy, one-weekly 2.4 mg semaglutide injection for treating metabolic-associated ...

1don MSN

Novo Nordisk Stock Is Jumping. Weight-Loss Drug Wegovy Has Something to Do With It.

Novo Nordisk makes the wildly popular GLP-1 drug semaglutide which it sells under the brand name Wegovy for weight-loss and ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results